Google's Life Sciences is now a standalone entity that will be a wholly owned subsidiary of Alphabet after being under Google X.

According to Alphabet President Sergey Brin, Google Life Sciences head Andy Conrad would still head the department. In a Google+ post, Brin said only the reporting structure will change, but the goal will still be the same. The team will continue to work with other life sciences companies to transition new technologies from R&D stage to clinical testing. This will enhance the way diseases are detected, prevented, and managed.

Brin said, it's a huge undertaking and he announced that the life sciences team ready to graduate from their X lab to become a standalone Alphabet company. "The team is relatively new but very diverse including software engineers, oncologists, and optics experts," he said, adding, "This is the type of company we hope will thrive as part of Alphabet and I can't wait to see what they do next."

One of the major products that the team invented while with Google X is the glucose monitoring contact lenses, which helps diabetics monitor their blood sugar levels. This was a project the team developed three years ago. They integrated computing inside the contact lens. It can read glucose level through tears, which is very difficult to analyse.

Brin is happy for the progress of this project, but he never imagined the "potential of initiative it has grown into," which is a life sciences team that aims to create new technologies that would improve the healthcare industry into a more productive one.

This contact lens project paved way to nanodiagnostics platform, which is a cardiac and activity monitor. There are evidences showing that Google is making big progress on the lens and will be marketed very soon.